DSM Buys Device Component Maker Kensey Nash To Bolster Biomedical Materials Offerings
This article was originally published in The Gray Sheet
Deal worth $360 million will help establish DSM as a major device industry materials supplier, strengthening offerings of bio-passive, bio-active and bio-interactive materials technologies.
You may also be interested in...
Kensey Nash and St. Jude Medical settle royalties spat. More news briefs.
Kensey Nash picks up Norian
With price controls in Medicare looming nine years after approval, launch strategies such as ‘bridge’ programs that build initial volume with free drug may have to be adjusted.